Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
Josepmaria Argemí, M. Ujúe Latasa, Stephen R. Atkinson, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Bedair Dewidar, Christoph Meyer, Steven Dooley, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1419-1419
Open Access | Times Cited: 586
An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis
Juan Pablo Arab, Tejasav S. Sehrawat, Douglas A. Simonetto, et al.
Hepatology (2019) Vol. 72, Iss. 2, pp. 441-453
Open Access | Times Cited: 152
Alcohol-Associated Hepatitis
Ramón Bataller, Juan Pablo Arab, Vijay H. Shah
New England Journal of Medicine (2022) Vol. 387, Iss. 26, pp. 2436-2448
Closed Access | Times Cited: 142
Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Xiaoqin Wu, Xiude Fan, Tatsunori Miyata, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 411-438
Open Access | Times Cited: 141
Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model
Taihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1420-1433
Open Access | Times Cited: 119
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 101
Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis
Mohamed Bou Saleh, Alexandre Louvet, Line Carolle Ntandja‐Wandji, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 4, pp. 912-923
Open Access | Times Cited: 57
Loss of liver function in chronic liver disease: An identity crisis
Carmen Berasain, María Arechederra, Josepmaria Argemí, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 401-414
Open Access | Times Cited: 52
Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure
Jing Ma, Adrien Guillot, Zhihong Yang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 14
Open Access | Times Cited: 49
Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice
Robert N. Helsley, Tatsunori Miyata, Anagha Kadam, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 39
Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder
Juan Pablo Arab, Giovanni Addolorato, Philippe Mathurin, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2124-2134
Open Access | Times Cited: 29
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis
Tarek Hassanein, Craig J. McClain, Vatsalya Vatsalya, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1, pp. 107-115
Open Access | Times Cited: 24
Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation
Jay Luther, Sanjoy K. Khan, Manish Gala, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 21, pp. 11667-11673
Open Access | Times Cited: 67
A review on molecular mechanism of alcoholic liver disease
Arunraj Namachivayam, Abilash Valsala Gopalakrishnan
Life Sciences (2021) Vol. 274, pp. 119328-119328
Closed Access | Times Cited: 54
Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology
Vanessa Dubois, Bart Staels, Philippe Lefèbvre, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2185-2185
Open Access | Times Cited: 51
Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol‐Associated Liver Injury
Asmita Choudhury, Daniel Bullock, Arlene Lim, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 6, pp. 1300-1311
Open Access | Times Cited: 50
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease
Yi Duan, Huikuan Chu, Katharina Brandl, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Gene Deconvolution Reveals Aberrant Liver Regeneration and Immune Cell Infiltration in Alcohol‐Associated Hepatitis
Adam Kim, Xiaoqin Wu, Daniela Allende, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 987-1002
Open Access | Times Cited: 44
Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events
Thierry Gustot, Vanessa Stadlbauer, Wim Laleman, et al.
Journal of Hepatology (2021) Vol. 75, pp. S36-S48
Open Access | Times Cited: 41
Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans
Sumedha Gunewardena, Ian Huck, Chad Walesky, et al.
Hepatology (2022) Vol. 76, Iss. 2, pp. 372-386
Open Access | Times Cited: 35
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
Aitor Odriozola, Álvaro Santos‐Laso, María Del Barrio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7791-7791
Open Access | Times Cited: 18
Sepsis-induced endothelial dysfunction drives acute-on-chronic liver failure through Angiopoietin-2-HGF-C/EBPβ pathway
Grant Elias, Michael Schonfeld, Sara Saleh, et al.
Hepatology (2023) Vol. 78, Iss. 3, pp. 803-819
Open Access | Times Cited: 16
Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis
Xiaojuan Chao, Shaogui Wang, Xiaowen Ma, et al.
Hepatology (2023) Vol. 78, Iss. 2, pp. 503-517
Closed Access | Times Cited: 16
Advances in the understanding and management of alcohol-related liver disease
Mark Thursz, Anne Lingford‐Hughes
BMJ (2023), pp. e077090-e077090
Closed Access | Times Cited: 16
MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis
Natalia Pydyn, Anna Ferenc, Katarzyna Trzos, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 6, pp. 887-906
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top